
UT Southwestern Study Finds Liver Fat-Making Enzymes Gather in a Complex
A Nov. 19 UT Southwestern release describes a study, led by Jay Horton, suggesting enzymes that make fat in the liver gather into a working complex. The work was done in cells and animal models and is not a treatment.
Enzymes that make fat in the liver come from different parts of the cell and gather into a working unit, a study led by UT Southwestern Medical Center researchers suggests, according to a university release dated Nov. 19.
The work was done in liver cells and animal models, not in patients, and does not establish a treatment. The findings, published in the journal Molecular Cell, according to the university, could point toward new research paths on fatty liver disease — known clinically as metabolic dysfunction-associated steatotic liver disease, or MASLD — a condition the release says affects over a third of U.S. adults. That prevalence figure is UT Southwestern's statement in the release; this report does not independently recalculate it.
"In MASLD, rates of fat synthesis are too high, resulting in excessive fat accumulation in the liver. Reducing fat synthesis by disrupting the formation of this enzyme complex may provide a new therapeutic opportunity to treat fatty liver disease," said study leader Jay Horton, M.D., director of the Center for Human Nutrition and professor of internal medicine and molecular genetics at UT Southwestern.
The release describes MASLD as a leading cause of cirrhosis and liver cancer, spurred by an epidemic of excess body weight and obesity worldwide. Over recent decades, research at UT Southwestern and elsewhere has identified a cascade of enzymes that produce fat in liver cells through a stepwise process. Because those enzymes are based in different cellular locations, Horton said, how they work together to generate fat had been a mystery.
To look at that question, he and colleagues in the Horton Lab used immunoprecipitation, a method that uses antibodies to pull molecules of interest out of a cell, along with other molecules they interact with. Targeting an enzyme called ACC1, which the release says is central to liver fat synthesis and is typically found in the liquid portion of cells known as the cytosol, the researchers pulled out other enzymes in the same fat-producing cascade that are based in organelles including mitochondria and the endoplasmic reticulum.
A second method, immunofluorescence, which makes antibody-tagged molecules glow, showed that these enzymes were often grouped together around lipid droplets, which act as fat storage depots in cells. The researchers saw significantly more of these enzyme complexes in liver cells from animal models fed diets that encouraged fat production, or that were genetically predisposed to MASLD, than in animals that ate standard laboratory chow. The release does not give animal counts or diet formulas, and those details are not added here.
The enzymes might be found together because they form a metabolon — a complex of enzymes and related proteins that perform reactions in sequence as part of the same molecular cascade. Being physically close, the release explains, helps the next enzyme in the sequence act on the product of the previous one. The metabolon concept was popularized in the early 1970s by Paul Srere, Ph.D., a biochemist at UT Southwestern, who coined the term in a lecture in Hungary in 1985.
How these enzymes come together in liver cells is still unclear, Horton said, and will be a topic for future research in his lab. Learning more about that process, he added, could reveal ways to interfere with it and offer a new avenue for treating MASLD. That is a research aim, not a treatment that has been tested in patients or approved for fatty liver disease. The Nov. 19 release does not report a human clinical trial or a drug candidate arising from this work.
Horton also serves as director of the Nutrition and Obesity Research Center at UT Southwestern and is a member of the Harold C. Simmons Comprehensive Cancer Center. He holds the Distinguished University Chair in Human Nutrition, the Center for Human Nutrition Director's Endowed Chair, and the Scott Grundy Director's Chair.
Other UT Southwestern researchers named in the release are co-first authors Xiaotong Zhu, Ph.D., assistant professor, and Chai-Wan Kim, Ph.D., associate professor, both in the Center for Human Nutrition and of Internal Medicine; Shawn C. Burgess, Ph.D., professor in the Center for Human Nutrition and of Pharmacology; and Xiaorong Fu, Ph.D., associate professor in the Center for Human Nutrition and of Internal Medicine.


